期刊
ENFERMERIA CLINICA
卷 30, 期 -, 页码 499-505出版社
ELSEVIER ESPANA SLU
DOI: 10.1016/j.enfcli.2019.07.147
关键词
Preectampsia; Aspirin; Pravastatin; Pregnancy outcome
类别
Objective: This study aimed to evaluate the effect of aspirin and pravastatin compared with aspirin on endothelin-1 levels, and the pregnancy outcome in pregnant women high risk for preeclampsia. Methods: It was a randomized clinical trial (RCT) analysis with block permutation. The sample divided into two groups. Group A as control has given aspirin 80 mg and group B as an intervention group given aspirin 80 mg plus pravastatin 20 mg twice daily until 35 weeks gestation. Level of Endothelin-1 examined before and after treatment. Results: There no differences found in endothelin-1 levels before and after being treated with aspirin or aspirin and pravastatin, as well as in the umbilical artery resistance index, fetal biometry, and the development of the fetus in two groups was typical at 28-32 weeks' gestation. Similarly, no differences found in fetal outcomes such as preterm birth, fetal growth retardation, and the incidence of preeclampsia between the two groups. Conclusion: As a conclusion, the administration of pravastatin, together with aspirin is no more effective than aspirin in preventing preectampsia, to pregnancy outcome and decreasing endothelin-1 levels. No congenital abnormalities reported. (C) 2019 Elsevier Espana, S.L.U. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据